Loading stock…

Ambuja Cements Limited (500425) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

Ambuja Cements Limited

500425Market cap $9.16BPrice $3.7

Country🇮🇳India

SectorMaterials

IndustryConstruction Materials

Manufactures cement and building materials that fuel India's construction boom, from highways to high-rises. Backed by Adani Group, it's one of India's largest cement producers, with capacity exceeding 100 million tonnes annually.

In Bastion Portfolios?

52W Return-42%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+5%5

Revenue Forecast

Rev CAGR (1y)+6%5

Rev CAGR (3y)+9%6

Rev CAGR (5y)+12%8

Earnings Forecast

EPS Growth Y+1-58%1

EPS Growth Y+2+74%10

EPS Growth Y+3+28%8

Quality

Margins

EBIT Margin7%3

Net Income Margin11%6

Free Cash Flow Margin-2%2

Debt

Net Debt/EBITDA-0.010

Efficiency

ROE8%4

ROAna–

Earnings Stability44

GEAR+WEAK31

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)382

P/E Ratio (Forward 3y)193

P/BV1.58

EV Multiples

EV/EBITDA Fwd144

EV/EBIT Fwd362

Yield

Free Cash Flow Yield-1.1%2

Dividend Yield0.6%2

Momentum

Short term

1 month return-11%2

3 month return-16%2

YTD return-36%1

Mid term

Price vs 52wHigh61%2

1 year return-37%1

Long term

3 year return-18%2

5 year return-9%3

Risk Shield

Price Risk

Beta0.57

Volatility28%8

Free Cash Flow

Free Cash Flow Margin-2%2

Free Cash Flow Yield-1.1%2

Quality

ROCE7%4

Earnings Stability44

Net Debt/EBITDA-0.010

02Growth

Is it actually growing, and how fast?

500425Ambuja Cements

Revenue FY26$4.4B

GROWTH RATING↗

AVERAGE60 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+5%5

Revenue, next 1Y+6%5

Revenue, next 3Y, CAGR+9%6

Revenue, next 5Y, CAGR+12%8

EARNINGS FORECAST▾SCORE

EPS growth, FY27E-58%1

EPS growth, FY28E+74%10

EPS growth, FY29E+28%8

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 5%/yr over the last 3 years and is set to grow 9%/yr from here.

The runway holds up: revenue is set to grow 12%/yr over five years.8/10

WATCH

A mid-pack grower, ahead of 60% of companies worldwide.

Revenue is set to grow 9%/yr over the next 3 years, a little ahead of the market.6/10

Earnings are set to grow faster than sales (EPS about 28%/yr vs revenue 9%/yr), so margins should widen. One year dips: EPS falls 58% next year.

WEAKNESSES

None flagged.

BOTTOM LINE

Reaccelerating Grower

A middle-of-the-pack grower that's speeding up. The one thing to watch: the earnings path has a down year.

03Price Momentum

Is the market behind it right now?

500425Ambuja Cements

Total return Current11.5%

Price return Current0.6%

MOMENTUM RATING↗

VERY WEAK4 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-11%2

3-month return-16%2

YTD return-36%1

MID & LONG-TERM▾SCORE

% of 52-week high61%2

1-year return-37%1

3-year return-18%2

5-year return-9%3

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-18% over three years and -8.5% over five), behind 70% of the market.

It's down 37% over the past year, now 39% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-11%), over three months (-16%) and so far this year (-36%).

BOTTOM LINE

Falling Knife

Returns rank poorly over both the short and long run, and the price is still falling. Momentum is firmly negative — catching this is a bet against the tape, not with it. Wait for a base to form. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Ambuja Cements. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

500425Ambuja Cements

Revenue FY26$4.4B

GROWTH RATING↗

AVERAGE60 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+5%5

Revenue, next 1Y+6%5

Revenue, next 3Y, CAGR+9%6

Revenue, next 5Y, CAGR+12%8

EARNINGS FORECAST▾SCORE

EPS growth, FY27E-58%1

EPS growth, FY28E+74%10

EPS growth, FY29E+28%8

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 5%/yr over the last 3 years and is set to grow 9%/yr from here.

The runway holds up: revenue is set to grow 12%/yr over five years.8/10

WATCH

A mid-pack grower, ahead of 60% of companies worldwide.

Revenue is set to grow 9%/yr over the next 3 years, a little ahead of the market.6/10

Earnings are set to grow faster than sales (EPS about 28%/yr vs revenue 9%/yr), so margins should widen. One year dips: EPS falls 58% next year.

WEAKNESSES

None flagged.

BOTTOM LINE

Reaccelerating Grower

A middle-of-the-pack grower that's speeding up. The one thing to watch: the earnings path has a down year.

03Price Momentum

Is the market behind it right now?

500425Ambuja Cements

Total return Current11.5%

Price return Current0.6%

MOMENTUM RATING↗

VERY WEAK4 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-11%2

3-month return-16%2

YTD return-36%1

MID & LONG-TERM▾SCORE

% of 52-week high61%2

1-year return-37%1

3-year return-18%2

5-year return-9%3

MOMENTUM ASSESSMENT

STRENGTHS

None flagged.

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (-18% over three years and -8.5% over five), behind 70% of the market.

It's down 37% over the past year, now 39% below its 52-week high. That is lagging the market.

The stock is underperforming over the past month (-11%), over three months (-16%) and so far this year (-36%).

BOTTOM LINE

Falling Knife

04Value

Are you paying a fair price for it?

Stop guessing on Ambuja Cements. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community